Advanced Cancer Therapeutics Enters Phase 1 Human Clinical Trials With First-in-Class Anti-Cancer Drug Candidate LOUISVILLE, Ky., June 4, 2014 (GLOBE NEWSWIRE) -- Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, announced today that it has...

Advanced Cancer Therapeutics Awarded Phase I SBIR Grant to Develop Anti-cancer Drug for Novel Cancer Metabolism Target LOUISVILLE, Ky., Oct. 11, 2012 (GLOBE NEWSWIRE) -- Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, announced today that it has...

U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cancer Therapeutics' Anti-Cancer Product Portfolio LOUISVILLE, Ky., April 3, 2012 (GLOBE NEWSWIRE) -- Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today announced that it has...